NEW: Advances in Bioanalysis



Today’s drug development pipeline is filled with an arsenal of biomolecules of all shapes and sizes, from peptides and antibodies to antibody-drug conjugates, small molecules and oligonucleotides. The drug development process is pressured by the need for thorough bioanalysis to understand the physiological effects of candidate drugs including assessment of pharmacokinetics, pharmaco...